• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微生物假说:腺病毒感染和代谢性内毒素血症对肥胖发病机制的作用

The Microbial Hypothesis: Contributions of Adenovirus Infection and Metabolic Endotoxaemia to the Pathogenesis of Obesity.

作者信息

Tambo Amos, Roshan Mohsin H K, Pace Nikolai P

机构信息

Centre for Molecular Medicine and Biobanking, University of Malta, Msida, Malta.

出版信息

Int J Chronic Dis. 2016;2016:7030795. doi: 10.1155/2016/7030795. Epub 2016 Nov 24.

DOI:10.1155/2016/7030795
PMID:28004036
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5143720/
Abstract

The global obesity epidemic, dubbed "globesity" by the World Health Organisation, is a pressing public health issue. The aetiology of obesity is multifactorial incorporating both genetic and environmental factors. Recently, epidemiological studies have observed an association between microbes and obesity. Obesity-promoting microbiome and resultant gut barrier disintegration have been implicated as key factors facilitating metabolic endotoxaemia. This is an influx of bacterial endotoxins into the systemic circulation, believed to underpin obesity pathogenesis. Adipocyte dysfunction and subsequent adipokine secretion characterised by low grade inflammation, were conventionally attributed to persistent hyperlipidaemia. They were thought of as pivotal in perpetuating obesity. It is now debated whether infection and endotoxaemia are also implicated in initiating and perpetuating low grade inflammation. The fact that obesity has a prevalence of over 600 million and serves as a risk factor for chronic diseases including cardiovascular disease and type 2 diabetes mellitus is testament to the importance of exploring the role of microbes in obesity pathobiology. It is on this basis that Massachusetts General Hospital is sponsoring the Faecal Microbiota Transplant for Obesity and Metabolism clinical trial, to study the impact of microbiome composition on weight. The association of microbes with obesity, namely, adenovirus infection and metabolic endotoxaemia, is reviewed.

摘要

全球肥胖流行被世界卫生组织称为“全球肥胖症”,是一个紧迫的公共卫生问题。肥胖的病因是多因素的,包括遗传和环境因素。最近,流行病学研究观察到微生物与肥胖之间存在关联。促进肥胖的微生物群以及由此导致的肠道屏障破坏被认为是促进代谢性内毒素血症的关键因素。这是细菌内毒素流入体循环,被认为是肥胖发病机制的基础。脂肪细胞功能障碍以及随后以低度炎症为特征的脂肪因子分泌,传统上归因于持续的高脂血症。它们被认为在肥胖的持续发展中起关键作用。现在人们争论感染和内毒素血症是否也与低度炎症的发生和持续有关。肥胖症患病率超过6亿,并且是包括心血管疾病和2型糖尿病在内的慢性疾病的危险因素,这一事实证明了探索微生物在肥胖病理生物学中的作用的重要性。在此基础上,麻省总医院正在赞助肥胖与代谢粪便微生物群移植临床试验,以研究微生物群组成对体重的影响。本文综述了微生物与肥胖的关联,即腺病毒感染和代谢性内毒素血症。

相似文献

1
The Microbial Hypothesis: Contributions of Adenovirus Infection and Metabolic Endotoxaemia to the Pathogenesis of Obesity.微生物假说:腺病毒感染和代谢性内毒素血症对肥胖发病机制的作用
Int J Chronic Dis. 2016;2016:7030795. doi: 10.1155/2016/7030795. Epub 2016 Nov 24.
2
Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.肠道微生物群控制脂肪组织扩张、肠道屏障和葡萄糖代谢:对使用益生元的分子靶点和干预措施的新见解。
Benef Microbes. 2014 Mar;5(1):3-17. doi: 10.3920/BM2012.0065.
3
Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.肠道微生物群中双歧杆菌的选择性增加通过与内毒素血症相关的机制改善高脂饮食诱导的小鼠糖尿病。
Diabetologia. 2007 Nov;50(11):2374-83. doi: 10.1007/s00125-007-0791-0. Epub 2007 Sep 6.
4
Diabetes, obesity and gut microbiota.糖尿病、肥胖与肠道菌群。
Best Pract Res Clin Gastroenterol. 2013 Feb;27(1):73-83. doi: 10.1016/j.bpg.2013.03.007.
5
Gut Microbiota Mediates the Protective Effects of Dietary Capsaicin against Chronic Low-Grade Inflammation and Associated Obesity Induced by High-Fat Diet.肠道微生物群介导膳食辣椒素对高脂饮食诱导的慢性低度炎症和相关肥胖的保护作用。
mBio. 2017 May 23;8(3):e00470-17. doi: 10.1128/mBio.00470-17.
6
Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease.肠道来源的低水平内毒素血症、动脉粥样硬化血栓形成和心血管疾病。
Nat Rev Cardiol. 2023 Jan;20(1):24-37. doi: 10.1038/s41569-022-00737-2. Epub 2022 Jul 15.
7
The gut microbiome and elevated cardiovascular risk in obesity and autoimmunity.肠道微生物组与肥胖和自身免疫中的心血管风险升高。
Atherosclerosis. 2018 Apr;271:203-213. doi: 10.1016/j.atherosclerosis.2018.02.036. Epub 2018 Mar 2.
8
Crosstalk between intestinal microbiota, adipose tissue and skeletal muscle as an early event in systemic low-grade inflammation and the development of obesity and diabetes.肠道微生物群、脂肪组织和骨骼肌之间的相互作用是全身低度炎症以及肥胖和糖尿病发生发展过程中的早期事件。
Diabetes Metab Res Rev. 2015 Sep;31(6):545-61. doi: 10.1002/dmrr.2617. Epub 2014 Dec 8.
9
Clinical significance of translocation.易位的临床意义。
Gut. 1994 Jan;35(1 Suppl):S28-34. doi: 10.1136/gut.35.1_suppl.s28.
10
[Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].[肠道微生物群的生理模式。肠道菌群失调在肥胖、胰岛素抵抗、糖尿病和代谢综合征中的作用]
Orv Hetil. 2016 Jan 3;157(1):13-22. doi: 10.1556/650.2015.30296.

引用本文的文献

1
New Pandemic: Obesity and Associated Nephropathy.新的大流行疾病:肥胖症及相关肾病。
Front Med (Lausanne). 2021 Jun 29;8:673556. doi: 10.3389/fmed.2021.673556. eCollection 2021.
2
Adenovirus infection is associated with altered gut microbial communities in a non-human primate.腺病毒感染与非人类灵长类动物肠道微生物群落的改变有关。
Sci Rep. 2019 Sep 16;9(1):13410. doi: 10.1038/s41598-019-49829-z.
3
Mechanisms underlying the weight loss effects of RYGB and SG: similar, yet different.RYGB 和 SG 减轻体重作用的机制:相似,但又有所不同。
J Endocrinol Invest. 2019 Feb;42(2):117-128. doi: 10.1007/s40618-018-0892-2. Epub 2018 May 5.

本文引用的文献

1
Human Adenovirus 36 Infection Increased the Risk of Obesity: A Meta-Analysis Update.人腺病毒36感染增加肥胖风险:一项荟萃分析更新
Medicine (Baltimore). 2015 Dec;94(51):e2357. doi: 10.1097/MD.0000000000002357.
2
Endocannabinoids--at the crossroads between the gut microbiota and host metabolism.内源性大麻素——肠道微生物群和宿主代谢的交汇点。
Nat Rev Endocrinol. 2016 Mar;12(3):133-43. doi: 10.1038/nrendo.2015.211. Epub 2015 Dec 18.
3
Adenovirus 36 and Obesity: An Overview.腺病毒36与肥胖:概述
Viruses. 2015 Jul 8;7(7):3719-40. doi: 10.3390/v7072787.
4
GLP-1R agonists promote normal and neoplastic intestinal growth through mechanisms requiring Fgf7.GLP-1R 激动剂通过需要 Fgf7 的机制促进正常和肿瘤性肠道生长。
Cell Metab. 2015 Mar 3;21(3):379-91. doi: 10.1016/j.cmet.2015.02.005.
5
Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions.脂肪组织免疫反应:慢性炎症性疾病的新型触发因素及后果
Inflammation. 2014 Aug;37(4):1337-53. doi: 10.1007/s10753-014-9914-1.
6
The clinical and economic consequences of obesity.肥胖的临床及经济后果。
Am J Manag Care. 2013 Aug;19(11 Suppl):s219-28.
7
Adenovirus vectors for gene therapy, vaccination and cancer gene therapy.腺病毒载体用于基因治疗、疫苗接种和癌症基因治疗。
Curr Gene Ther. 2013 Dec;13(6):421-33. doi: 10.2174/1566523213666131125095046.
8
Gut barrier dysfunction and microbial translocation in cancer cachexia: a new therapeutic target.肠道屏障功能障碍和肿瘤恶病质中的微生物易位:一个新的治疗靶点。
Curr Opin Support Palliat Care. 2013 Dec;7(4):361-7. doi: 10.1097/SPC.0000000000000017.
9
Obesity as a major risk factor for cancer.肥胖是癌症的主要风险因素。
J Obes. 2013;2013:291546. doi: 10.1155/2013/291546. Epub 2013 Aug 29.
10
The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis.Apelin 受体 APJ:从孤儿受体到维持内环境稳定的多功能调节剂的历程。
J Endocrinol. 2013 Sep 11;219(1):R13-35. doi: 10.1530/JOE-13-0227. Print 2013 Oct.